Comparison of aromatase expression in endometrial polyps between premenopausal and postmenopausal period
SUN Shuhong1, WANG Shuhe2, SUN Yanbin3, ZHAO Qiaomian1, JI Hailian1, YU Shuli1, XU Jinhuan1, MA Xiuqin1
1. Department of Gynecology, Chengde Maternal and Child Health Hospital of Hebei Province, Chengde 067000, China; 2. Department of Gynecology and Obstetrics, Beijing Military Command General Hospital, Beijing 100700, China; 3. Department of Anesthesiology, Chengde Central Hospital of Hebei Province, Chengde 067000, China
Abstract：Objective To investigate the differences of aromatase expression in endometrial polyps between premenopausal and postmenopausal periods. Methods According to menstrual status, the patients were divided into different groups: premenopausal group and postmenopausal group. According to the strict exclusion criteria, 20 patients were selected into each group. The postmenopausal endometrial polyps were sampled as the experiment group 1, while the postmenopausal remoteendometrial tissues not belonging to the polyp were sampled as the control group 1. The premenopausal endometrial polyps were sampled as the experiment group 2, while the premenopausal remote endometrial tissues not belonging to the polyp were sampled as the control group 2. All patients underwent hysteroscopic resection of endometrial polyps. Immunohistochemistry was used to detect the expression of aromatase in endometrial polyps and the remote endometrial tissues. Images were analyzed by using Image-Pro Plus 6.0 analysis software. The mean optical density values of aromatase expression were taken as comparison index. Results The expressions of aromatase in experiment group 1 and group 2 were 0.1001±0.0140 and 0.0651±0.0098, the differences was statistically significant (t=9.16, P＜0.01). The expressions of aromatase in control group 1 and group 2 were 0.0269±0.0066 and 0.0342±0.0083, the differences between two groups was no statistically significant. The expressions of aromatase in two experiment groups were higher than in two corresponding control groups, the differences were statistically significant (t=21.16, P＜0.01; t=8.49, P＜0.01). Conclusions The presence of aromatase expression is significantly higher in endometrial polyps than in endometriam, both in premenopausal and in postmenopausal period. The expression of aromatase in postmenopausal endometrial polyps is higher than in premenopausal endometrial polyps, so the pathogenesis of endometrial polyps may be different in the two different physiological stages.
Indraccolo U, Di Iorio R, Matteo M, et al. The pathogenesis of endometrial polyps: a systematic semi-quantitative review[J]. Eur J Gynaecol Oncol, 2013,34(1):5-22.
Dreisler E, Sorensen S S, Ibsen P H, et al. Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20-74 years [J]. Ultrasound Obstet Gynecd, 2009,33(1):102-108.
[3]
肖 佩, 王树鹤. 不同生理阶段子宫内膜息肉的临床分析[D].安徽医科大学, 2014.
[18]
Gurates B,Sebastian S,Yang S,et al.WTI and DAX-1 inhibit aromatase P450 expression in human endometrial and endometriotid stromal cells[J].J Clin Endocrinol Metab, 2002, 87(9):4369-4377.
[4]
Lee S C,Kaunitz A M,Ramos S,et al. The oncogenic potential of endometrial polyps: a systematic review and meta analysis[J]. Obstet Gynecol,2010,116(5): 1197-1205.
Biron S T, Tepper R. A comparison of oestrogen receptor and progesterone receptorexpression in endometrial polyps and endometrium of premenopausal women [J]. J Obstet Gynaecol,2009,29(4):340-346.
[7]
De Carvalho S, Campaner A B, Lima S M, et al. Differential expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women [J]. Anal Quant Cytol Histol, 2011,33(2):61-67.
[8]
Erdemoglu E, Güney M, Karahan N, et al. Expression of cyclooxygenase-2, matrix metalloproteinase-2 and matrix metalloproteinase-9 in premenopausal and postmenopausal endometrial polyps [J]. Maturitas, 2008,59(3):268-274.
[9]
Antunes A Jr, AndradeLA, Pinto G A, et al. Is the immunohistochemical expression of proliferation (Ki-67) and apoptosis (Bcl-2) markers and cyclooxigenase-2 (COX-2) related to carcinogenesis in postmenopausal endometrial polyps[J]. Anal Quant Cytopathol Histpathol,2012,34(5):264-272.
[10]
Meinhardt U, Mullis P E. The aromatase cytochrome P450 and its clinical impact [J]. Horm Res, 2002,57(5-6):145-152.
[11]
Sumitani H, Shozu M, Segawa T, et al. In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via anautocrine/intracrine mechanism [J]. Endocrinology, 2000,141(10):3852-3861.
[12]
Shozu M, Fukami M, Ogata T. Understanding the pathological manifestations of aromatase excess syndrome: lessons for clinical diagnosis [J]. Expert Rev Endocrinol Metab, 2014,9(4):397-409.
[13]
Ksenia C, Farzad P, Helmut S, et al. Interference of endocrine disrupting chemicals with aromatase CYP19 expression or activity, and consequences for reproduction of teleost fish [J]. Gen Comp Endocrinol, 2008,155(1):31-62.
Biron S T, Tepper R, Fishman A, et al. Recurrent endometrial polyps in postmenopausal breast cancer patientson tamoxifen [J]. Gynecol Oncol, 2003,90(2):382-386.
[16]
Maia H Jr,Pimentel K,Silva T M,et al. Aromatase and cyclooxygenase-2 expression in endometrial polyps during the menstrual cycle[J]. Gynecol Endocrinol,2006,22(4):219-224.
2015, Vol. 26 
